Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
Christopher Robinson, Physician, Partner at Charleston Maternal Fetal Medicin, shared a post on LinkedIn about a recent article by Kelly Ferguson et al, published in American Journal of Obstetrics Gynecology, adding:
“Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction – Pathways of oxylipin production and obstetric relevance.”
Title: Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction
Authors: Kelly K. Ferguson, Barrett M. Welch, Danielle R. Stevens, Paige A. Bommarito, Ginger L. Milne, John D. Meeker, Matthew L. Edin, Darryl C. Zeldin, David E. Cantonwine, Thomas F. McElrath
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters